Zdzislaw M Szulc Selected Research

D- erythro- 2- N- (160- (1''- pyridinium)hexadecanoyl)sphingosine bromide

9/2013

Cationic ceramides and analogues, LCL30 and LCL85, as adjuvants to photodynamic therapy of tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zdzislaw M Szulc Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 02/2008
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2020 - 01/2016
2	Lung Neoplasms (Lung Cancer) 11/2019 - 01/2013
2	Prostatic Neoplasms (Prostate Cancer) 12/2017 - 02/2008
2	Squamous Cell Carcinoma of Head and Neck 01/2017 - 01/2005
1	Arthritis (Polyarthritis) 11/2020
1	Experimental Arthritis 11/2020
1	Multiple Sclerosis 11/2020
1	Infections 01/2017
1	Splenomegaly 01/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017
1	Colitis 01/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016
1	Glioma (Gliomas) 10/2013
1	Necrosis 01/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2013
1	Neurilemmoma (Schwannoma) 07/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2012
1	Neuroblastoma 06/2007

Drug/Important Bio-Agent (IBA)

16	CeramidesIBA 09/2020 - 01/2005
8	SphingolipidsIBA 11/2020 - 09/2010
7	Acid CeramidaseIBA 01/2022 - 02/2008
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2010
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 09/2013
4	SphingosineIBA 09/2020 - 02/2011
4	dihydroceramide desaturaseIBA 09/2013 - 06/2007
3	LCL521IBA 01/2022 - 01/2016
3	sphingosine kinaseIBA 09/2020 - 09/2013
3	Pharmaceutical PreparationsIBA 11/2019 - 01/2013
3	Fingolimod Hydrochloride (FTY720)FDA Link 11/2019 - 01/2013
3	BromidesIBA 01/2013 - 02/2011
2	Phosphotransferases (Kinase)IBA 11/2019 - 12/2017
2	Nonmuscle Myosin Type IIAIBA 11/2019 - 01/2019
2	N-palmitoylsphingosineIBA 10/2018 - 09/2013
2	EnzymesIBA 09/2013 - 06/2007
1	Histocompatibility Antigens Class IIIBA 11/2020
1	CytokinesIBA 11/2020
1	PF-543IBA 09/2020
1	temoporfinIBA 09/2020
1	CeramidasesIBA 09/2020
1	Phosphates (Orthophosphate)IBA 09/2020
1	IsotopesIBA 01/2019
1	glycylpeptide N-tetradecanoyltransferaseIBA 12/2017
1	Androgen Receptors (Androgen Receptor)IBA 12/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Dextrans (Dextran)FDA Link 01/2017
1	2-N-(1'-carboxamidino)sphingosineIBA 01/2017
1	Nonesterified Fatty Acids (NEFA)IBA 01/2017
1	IsoenzymesIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2017
1	Retinoblastoma ProteinIBA 01/2017
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2017
1	fms-Like Tyrosine Kinase 3IBA 10/2016
1	VaccinesIBA 01/2016
1	Annexin A5IBA 10/2013
1	Coloring Agents (Dyes)IBA 10/2013
1	ChromatinIBA 10/2013
1	Caspase 3 (Caspase-3)IBA 10/2013
1	2'-hydroxy C16-ceramideIBA 10/2013
1	Photosensitizing Agents (Photosensitizers)IBA 09/2013
1	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 09/2013
1	PorphyrinsIBA 09/2013
1	D- erythro- 2- N- (160- (1''- pyridinium)hexadecanoyl)sphingosine bromideIBA 09/2013
1	silicon phthalocyanineIBA 09/2013
1	2- N- (6'- (1'- pyridinium)hexanoyl)sphingosineIBA 01/2013
1	Gemcitabine FDA Link 01/2013
1	Sodium SeleniteIBA 10/2012
1	Biotin (Vitamin H)FDA Link 07/2012
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2012
1	LipidsIBA 11/2010
1	RetinoidsIBA 09/2010
1	FenretinideIBA 09/2010
1	safingol (sphinganine)IBA 09/2010
1	Alkaline CeramidaseIBA 09/2010
1	CaspasesIBA 03/2009
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2005

Therapy/Procedure

6	Therapeutics 01/2022 - 11/2010
4	Photochemotherapy (Photodynamic Therapy) 01/2022 - 09/2013
3	Drug Therapy (Chemotherapy) 01/2017 - 01/2005
1	Cryosurgery 09/2020
1	Photothermal Therapy 09/2020
1	Radiotherapy 01/2017